A study in humans identified the mir-6722-5p as a biomarker for recurrent myocardial infarction risk, where it was downregulated in whole blood of patients with recurrent MI compared to those without in a replication cohort, remaining significant after false discovery rate correction, but it was not significantly different in plasma samples [Onuoha et al. DOI:10.1111/cts.13307].